Table 3 Comparison of treatment-associated features between TS-High and TS-Low risk groups in the Institutional-Transcriptomic cohort
Transcriptomic Risk Group | ||||
|---|---|---|---|---|
TS-High (n = 32) | TS-Low (n = 31) | p-value | ||
Type of surgery | Mastectomy | 17 (53.1) | 10 (32.3) | 0.128 |
Lumpectomy | 15 (46.9) | 21 (67.7) | ||
Pre-treatment longest tumor measurement, mean ± SD (cm) | 3.19 ± 2.36 | 2.31 ± 1.86 | 0.11 | |
Post-treatment longest tumor measurement, mean ± SD (cm) | 1.32 ± 2.19 | 0.86 ± 1.29 | 0.31 | |
Treatment response, n (%) | pCR | 6 (23.08) | 14 (45.2) | 0.047 |
Residual cancer burden | 1.82 ± 1.37 | 0.91 ± 1.15 | 0.006 | |
